Trial design STEMS is a prospective, therapeutic exploratory, non-randomized, open-label, single-dose-finding phase 1 clinical trial (NCT03269071, EudraCT2016-002020-86) conducted at San Raffaele Scientific Institute in Milan, Italy (Fig
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
This place has become one of my favourites for skin and hair treatments
Some adverse events attributed to peptides in clinical practice may reflect contamination or degradation rather than inherent pharmacologic toxicity
In the detection medium containing 32% ethanol, the adduct is poorly soluble and forms aggregates, thus switching on the fluorescence
Daily versus every other day protocols Daily injection provides the most consistent tissue levels